For citations:
Orlov S.V., Shimanovskii N.L., Fogt S.N. IS IT POSSIBLE TO USE BEVACIZUMAB BIOSIMILAR IN ALL INDICATIONS REGISTERED FOR ORIGINAL DRUG? Research and Practical Medicine Journal. 2016;3(2):45-52. (In Russ.) https://doi.org/10.17709/2409-2231-2016-3-2-6